Claims In Securities Class Action Against Drug Maker Found To Be Insufficient
NEW YORK — Although lead plaintiffs in a securities class action against a drug company and its co-founders have shown that the defendants acted with the requisite scienter, they have failed...To view the full article, register now.
Already a subscriber? Click here to view full article